Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs

Company's eTurna™ delivery platform ensures unprecedented precision, safety In-vivo biodistribution of mRNA into dermal cells, tissues shows high transfection efficiency, gene expressionData presented at ASDS Annual MeetingView original content:https://www.prnewswire.co.uk/news-releases/turn-biotechnologies-first-to-deliver-mrna-into-the-dermis-using-proprietary-lnps-with-no-distribution-to-other-organs-301977754.html

en | boerse | 67937266 |